A citation-based method for searching scientific literature

Naoki Oishi, Tetsuo Kondo, Aya Ebina, Yukiko Sato, Junko Akaishi, Rumi Hino, Noriko Yamamoto, Kunio Mochizuki, Tadao Nakazawa, Hiroshi Yokomichi, Koichi Ito, Yuichi Ishikawa, Ryohei Katoh. Mod Pathol 2017
Times Cited: 38







List of co-cited articles
350 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
464
52

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
258
36

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
363
34

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
28

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
303
28

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
28

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
382
26


TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
178
26

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
Eleonora Molinaro, Cristina Romei, Agnese Biagini, Elena Sabini, Laura Agate, Salvatore Mazzeo, Gabriele Materazzi, Stefano Sellari-Franceschini, Alessandro Ribechini, Liborio Torregrossa,[...]. Nat Rev Endocrinol 2017
159
23

Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases.
Benjamin Bonhomme, Yann Godbert, Gaelle Perot, Abir Al Ghuzlan, Stéphane Bardet, Geneviève Belleannée, Lise Crinière, Christine Do Cao, Geneviève Fouilloux, Serge Guyetant,[...]. Thyroid 2017
35
25

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
158
23

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Marina N Nikiforova, Edna T Kimura, Manoj Gandhi, Paul W Biddinger, Jeffrey A Knauf, Fulvio Basolo, Zhaowen Zhu, Riccardo Giannini, Giuliana Salvatore, Alfredo Fusco,[...]. J Clin Endocrinol Metab 2003
746
23


Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
519
21

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Nikita Pozdeyev, Laurie M Gay, Ethan S Sokol, Ryan Hartmaier, Kelsi E Deaver, Stephanie Davis, Jena D French, Pierre Vanden Borre, Daniel V LaBarbera, Aik-Choon Tan,[...]. Clin Cancer Res 2018
151
21

Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
Audrey Deeken-Draisey, Guang-Yu Yang, Juehua Gao, Borislav A Alexiev. Hum Pathol 2018
28
28

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
73
18

TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.
Miguel Melo, Adriana Gaspar da Rocha, Rui Batista, João Vinagre, Maria João Martins, Gracinda Costa, Cristina Ribeiro, Francisco Carrilho, Valeriano Leite, Cláudia Lobo,[...]. J Clin Endocrinol Metab 2017
61
18

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
John W Kunstman, C Christofer Juhlin, Gerald Goh, Taylor C Brown, Adam Stenman, James M Healy, Jill C Rubinstein, Murim Choi, Nimrod Kiss, Carol Nelson-Williams,[...]. Hum Mol Genet 2015
181
18

Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.
Marco Volante, Paola Collini, Yuri E Nikiforov, Atsuhiko Sakamoto, Kennichi Kakudo, Ryohei Katoh, Ricardo V Lloyd, Virginia A LiVolsi, Mauro Papotti, Manuel Sobrinho-Simoes,[...]. Am J Surg Pathol 2007
318
18

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.
Vivek Subbiah, Robert J Kreitman, Zev A Wainberg, Jae Yong Cho, Jan H M Schellens, Jean Charles Soria, Patrick Y Wen, Christoph Zielinski, Maria E Cabanillas, Gladys Urbanowitz,[...]. J Clin Oncol 2018
267
18

Anaplastic thyroid carcinoma: a 50-year experience at a single institution.
B McIver, I D Hay, D F Giuffrida, C E Dvorak, C S Grant, G B Thompson, J A van Heerden, J R Goellner. Surgery 2001
293
18


TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang,[...]. J Clin Endocrinol Metab 2014
180
15

Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma.
Maria E Cabanillas, Renata Ferrarotto, Adam S Garden, Salmaan Ahmed, Naifa L Busaidy, Ramona Dadu, Michelle D Williams, Heath Skinner, G Brandon Gunn, Horiana Grosu,[...]. Thyroid 2018
47
15

NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma.
Vera Tiedje, Saskia Ting, Thomas Herold, Sarah Synoracki, Soeren Latteyer, Lars C Moeller, Denise Zwanziger, Martin Stuschke, Dagmar Fuehrer, Kurt Werner Schmid. Oncotarget 2017
30
20

Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
Bin Xu, Talia Fuchs, Snjezana Dogan, Iñigo Landa, Nora Katabi, James A Fagin, R Michael Tuttle, Eric Sherman, Anthony J Gill, Ronald Ghossein. Thyroid 2020
27
22

Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.
R C Smallridge, J A Copland. Clin Oncol (R Coll Radiol) 2010
215
13

TERT promoter mutations and long-term survival in patients with thyroid cancer.
Tae Hyuk Kim, Young-Eun Kim, Soomin Ahn, Ji-Youn Kim, Chang-Seok Ki, Young Lyun Oh, Kyunga Kim, Jae Won Yun, Woong-Yang Park, Jun-Ho Choe,[...]. Endocr Relat Cancer 2016
46
13

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.
Langping Jin, Endong Chen, Siyang Dong, Yefeng Cai, Xiangjian Zhang, Yili Zhou, Ruichao Zeng, Fan Yang, Chuanmeng Pan, Yehuan Liu,[...]. Oncotarget 2016
74
13

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC.
Jonathan R George, Ying C Henderson, Michelle D Williams, Dianna B Roberts, Hu Hei, Stephen Y Lai, Gary L Clayman. J Clin Endocrinol Metab 2015
44
13

Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.
Marina Muzza, Carla Colombo, Stefania Rossi, Delfina Tosi, Valentina Cirello, Michela Perrino, Simone De Leo, Elisa Magnani, Elisa Pignatti, Beatrice Vigo,[...]. Mol Cell Endocrinol 2015
77
13

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park,[...]. Cancer 2016
89
13

Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.
Moira Ragazzi, Alessia Ciarrocchi, Valentina Sancisi, Greta Gandolfi, Alessandra Bisagni, Simonetta Piana. Int J Endocrinol 2014
73
13


Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area.
Min Ji Jeon, Sung-Min Chun, Deokhoon Kim, Hyemi Kwon, Eun Kyung Jang, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Se Jin Jang, Dong Eun Song,[...]. Thyroid 2016
42
13

TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours.
Johan O Paulsson, Ninni Mu, Ivan Shabo, Na Wang, Jan Zedenius, Catharina Larsson, C Christofer Juhlin. Endocr Relat Cancer 2018
26
19


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
13

Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
Seong-Keun Yoo, Young Shin Song, Eun Kyung Lee, Jinha Hwang, Hwan Hee Kim, Gyeongseo Jung, Young A Kim, Su-Jin Kim, Sun Wook Cho, Jae-Kyung Won,[...]. Nat Commun 2019
62
13

Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
Sarika N Rao, Mark Zafereo, Ramona Dadu, Naifa L Busaidy, Kenneth Hess, Gilbert J Cote, Michelle D Williams, William N William, Vlad Sandulache, Neil Gross,[...]. Thyroid 2017
54
13

Anaplastic carcinoma of the thyroid: a 24-year experience.
R K Tan, R K Finley, D Driscoll, V Bakamjian, W L Hicks, D P Shedd. Head Neck 1995
148
13

American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.
Robert C Smallridge, Kenneth B Ain, Sylvia L Asa, Keith C Bible, James D Brierley, Kenneth D Burman, Electron Kebebew, Nancy Y Lee, Yuri E Nikiforov, M Sara Rosenthal,[...]. Thyroid 2012
393
10


TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Greta Gandolfi, Moira Ragazzi, Andrea Frasoldati, Simonetta Piana, Alessia Ciarrocchi, Valentina Sancisi. Eur J Endocrinol 2015
78
10

Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Seung Eun Lee, Tae Sook Hwang, Yoon-La Choi, Hye Seung Han, Wan Seop Kim, Min Hye Jang, Suk Kyeong Kim, Jung Hyun Yang. Thyroid 2016
41
10

Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.
Xiaoguang Shi, Rengyun Liu, Shen Qu, Guangwu Zhu, Justin Bishop, Xiaoli Liu, Hui Sun, Zhongyan Shan, Enhua Wang, Yahong Luo,[...]. J Clin Endocrinol Metab 2015
56
10

Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.
Ja Seong Bae, Yourha Kim, Sora Jeon, Se Hee Kim, Tae Jung Kim, Sohee Lee, Min-Hee Kim, Dong Jun Lim, Youn Soo Lee, Chan Kwon Jung. Diagn Pathol 2016
41
10

TERT Promoter Mutations in Papillary Thyroid Microcarcinomas.
Dario de Biase, Greta Gandolfi, Moira Ragazzi, Markus Eszlinger, Valentina Sancisi, Mila Gugnoni, Michela Visani, Annalisa Pession, Gianpaolo Casadei, Cosimo Durante,[...]. Thyroid 2015
60
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.